Bio Platforms

EXECUTIVE INTERVIEW – Enteris BioPharma: Pioneers in Oral Formulation Development

Dr. Rajiv Khosla, CEO of Enteris BioPharma, discusses how his company’s innovative oral formulation technology is helping the pharmaceutical industry overcome the hurdle of low bioavailability to reshape treatment categories and expand market opportunities with minimal financial and regulatory risks.



XOMA Earns $2-Million Milestone From Takeda

XOMA Corporation recently announced it has earned a $2-million milestone payment from Takeda Pharmaceutical Company Limited as the first patient has been dosed….